The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Mohan outlines the key trends, strategies, and opportunities defining the ag inputs market in 2025 and beyond in this ...

A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a ...

President Trump announced that his administration would soon implement a “major tariff on pharmaceuticals” imported into the ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

In his concluding remarks, Dr. Jitendra Singh reflected on the future of India’s economy, which he asserted would be ...

Agri-biotech startup GreenGrahi has secured INR 32 Cr (around $3.7 Mn) in a seed funding round led by Avaana Capital ...

Indian IT outsourcing companies, which employ millions, are tapping artificial intelligence to boost efficiency and reduce ...

GreenGrahi leverages biotechnology and engineering to create premium insect-based ingredients and supplements for animal and ...

Improvements to the U.S. supply chain are needed to reduce shortages and protect American patients. Industry, academia, ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...